Re:Motley Fool

http://www.********.au/2014/10/24/c...ks-be-the-sirtex-medical-limited-of-tomorrow/

Anteo Diagnostics Ltd (ASX: ADO) has developed a unique technology that has application across the diagnostics and life science industries. The technology, known as Mix&Go, binds fragile biomolecules gently yet strongly to synthetic surfaces allowing for more sensitive and affordable diagnostic tests to be performed.
The company already boasts a market capitalisation of $125 million but there could still be significant upside if Anteo successfully commercialises its product. In the near term, an agreement with a leading healthcare company should result in Anteo earning a royalty on every test performed using an instrument containing its Mix&Go technology. Management has also provided guidance that it expects to close in excess of ten deals over the next four years.